Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 89 | NANETS2022 | Next issue

NANETS 2022

15th Annual Multidisciplinary NET Medical Symposium NANETS 2022

Clinical – Chemo/SSA/Biologics

Previous section
Basic Science
Table of contents
Next section
Clinical – Nuclear Medicine/Interventional Radiology/Imaging

ea0089c1 | Clinical – Chemo/SSA/Biologics

Progression-Free Survival in Patients with Bronchopulmonary Neuroendocrine Tumors Treated with Lanreotide or Placebo: Adjustment for Crossover Effects in Placebo Arm

ea0089c2 | Clinical – Chemo/SSA/Biologics

Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Neoplasms

ea0089c3 | Clinical – Chemo/SSA/Biologics

Real World Analysis of Long-Acting Somatostatin Analog (LA-SSA) Treatment and Dose Escalation Among Patients with Neuroendocrine Tumors (NET)

ea0089c4 | Clinical – Chemo/SSA/Biologics

Cisplatin vs Carboplatin in Extrapulmonary Poorly Differentiated Neuroendocrine Carcinomas (PD NEC)

ea0089c5 | Clinical – Chemo/SSA/Biologics

c-MET Expression in MEN1-associated Neuroendocrine Tumors

ea0089c6 | Clinical – Chemo/SSA/Biologics

An Open-Label, Phase 1b/2 study of Surufatinib in Combination with Tislelizumab in Patients with Advanced Neuroendocrine Tumors

ea0089c7 | Clinical – Chemo/SSA/Biologics

Risk of Myelodysplastic Syndrome/Acute Leukemia with Sequential Capecitabine/Temozolomide and 177Lu-Dotatate

ea0089c8 | Clinical – Chemo/SSA/Biologics

Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-Differentiated Neuroendocrine Tumors

ea0089c9 | Clinical – Chemo/SSA/Biologics

Correlation of MEN1 and DAXX Mutational Status with Response to Capecitabine and Temozolomide (CAPTEM) in Pancreatic Neuroendocrine Tumors

ea0089c10 | Clinical – Chemo/SSA/Biologics

ACTH-secreting Pancreatic Neuroendocrine Neoplasms: A Case-Series

ea0089c11 | Clinical – Chemo/SSA/Biologics

Results from the Phase 1, Randomized, Open-Label, Cross-Over Study to Evaluate Pharmacokinetics of Three Escalating Doses of Oral Octreotide Capsules

ea0089c12 | Clinical – Chemo/SSA/Biologics

Financial Toxicity and Supportive Care in Neuroendocrine Tumor: A Biobank Study

ea0089c13 | Clinical – Chemo/SSA/Biologics

Serum Serotonin Compared to Plasma 5-HIAA and Chromogranin A as Biomarkers of Response to Hepatic Artery Bland Embolization

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more